The prospects of cariprazine in the treatment of schizophrenia

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Therapeutic advances in psychopharmacology 2017-11, Vol.7 (11), p.237-239
1. Verfasser:	Scarff, Jonathan R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antipsychotics Schizophrenia
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	239
container_issue	11
container_start_page	237
container_title	Therapeutic advances in psychopharmacology
container_volume	7
creator	Scarff, Jonathan R.
description
doi_str_mv	10.1177/2045125317727260
format	Article
fullrecord	<record><control><sourceid>proquest_AFRWT</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5638160</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_2045125317727260</sage_id><sourcerecordid>1958544394</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-bbae3a5adfe9f960e3045b91dfc993e39a0d0e46b9fc34be70de97218106b55d3</originalsourceid><addsrcrecordid>eNp1UU1LAzEUDKLYUnv3JAtevKzme5tLQYpfUPBSzyGbfdumtLtrshXsrzdLa9WCueSRmTdvJg-hS4JvCcmyO4q5IFSwWNOMSnyC-t1TSqgkp4dasB4ahrDE8QjJqBLnqEcVVhiPZB-NZwtIGl-HBmwbkrpMrPGu8WbrKkhclbQRbz2Ydg1V2-HBLty2bhYeKmcu0FlpVgGG-3uA3h4fZpPndPr69DK5n6aWS9qmeW6AGWGKElSpJAYWzeWKFKVVigFTBhcYuMxVaRnPIcMFqIySEcEyF6JgAzTe6TabfA2FjV68WenGu7Xxn7o2Tv9FKrfQ8_pDx8gjInEUuNkL-Pp9A6HVaxcsrFamgnoTNFFiJDhnikfq9RF1WW98FeNpyimXkmS4Y-Edy8bPCx7KgxmCdbcffbyf2HL1O8Sh4XsbkZDuCMHM4Wfqv4Jfmp-Xyw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2424661704</pqid></control><display><type>article</type><title>The prospects of cariprazine in the treatment of schizophrenia</title><source>Sage Journals GOLD Open Access 2024</source><creator>Scarff, Jonathan R.</creator><creatorcontrib>Scarff, Jonathan R.</creatorcontrib><identifier>ISSN: 2045-1253</identifier><identifier>EISSN: 2045-1261</identifier><identifier>DOI: 10.1177/2045125317727260</identifier><identifier>PMID: 29090086</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Antipsychotics ; Schizophrenia</subject><ispartof>Therapeutic advances in psychopharmacology, 2017-11, Vol.7 (11), p.237-239</ispartof><rights>The Author(s), 2017</rights><rights>The Author(s), 2017. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at: https://uk.sagepub.com/en-gb/eur/reusing-open-access-and-sage-choice-content</rights><rights>The Author(s), 2017 2017 SAGE Publications</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-bbae3a5adfe9f960e3045b91dfc993e39a0d0e46b9fc34be70de97218106b55d3</citedby><cites>FETCH-LOGICAL-c462t-bbae3a5adfe9f960e3045b91dfc993e39a0d0e46b9fc34be70de97218106b55d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638160/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638160/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,725,778,782,883,21949,27836,27907,27908,44928,45316,53774,53776</link.rule.ids><linktorsrc>$$Uhttps://journals.sagepub.com/doi/full/10.1177/2045125317727260?utm_source=summon&utm_medium=discovery-provider$$EView_record_in_SAGE_Publications$$FView_record_in_$$GSAGE_Publications</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29090086$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Scarff, Jonathan R.</creatorcontrib><title>The prospects of cariprazine in the treatment of schizophrenia</title><title>Therapeutic advances in psychopharmacology</title><addtitle>Ther Adv Psychopharmacol</addtitle><subject>Antipsychotics</subject><subject>Schizophrenia</subject><issn>2045-1253</issn><issn>2045-1261</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNp1UU1LAzEUDKLYUnv3JAtevKzme5tLQYpfUPBSzyGbfdumtLtrshXsrzdLa9WCueSRmTdvJg-hS4JvCcmyO4q5IFSwWNOMSnyC-t1TSqgkp4dasB4ahrDE8QjJqBLnqEcVVhiPZB-NZwtIGl-HBmwbkrpMrPGu8WbrKkhclbQRbz2Ydg1V2-HBLty2bhYeKmcu0FlpVgGG-3uA3h4fZpPndPr69DK5n6aWS9qmeW6AGWGKElSpJAYWzeWKFKVVigFTBhcYuMxVaRnPIcMFqIySEcEyF6JgAzTe6TabfA2FjV68WenGu7Xxn7o2Tv9FKrfQ8_pDx8gjInEUuNkL-Pp9A6HVaxcsrFamgnoTNFFiJDhnikfq9RF1WW98FeNpyimXkmS4Y-Edy8bPCx7KgxmCdbcffbyf2HL1O8Sh4XsbkZDuCMHM4Wfqv4Jfmp-Xyw</recordid><startdate>20171101</startdate><enddate>20171101</enddate><creator>Scarff, Jonathan R.</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20171101</creationdate><title>The prospects of cariprazine in the treatment of schizophrenia</title><author>Scarff, Jonathan R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-bbae3a5adfe9f960e3045b91dfc993e39a0d0e46b9fc34be70de97218106b55d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Antipsychotics</topic><topic>Schizophrenia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Scarff, Jonathan R.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Nursing & Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Therapeutic advances in psychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Scarff, Jonathan R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The prospects of cariprazine in the treatment of schizophrenia</atitle><jtitle>Therapeutic advances in psychopharmacology</jtitle><addtitle>Ther Adv Psychopharmacol</addtitle><date>2017-11-01</date><risdate>2017</risdate><volume>7</volume><issue>11</issue><spage>237</spage><epage>239</epage><pages>237-239</pages><issn>2045-1253</issn><eissn>2045-1261</eissn><cop>London, England</cop><pub>SAGE Publications</pub><pmid>29090086</pmid><doi>10.1177/2045125317727260</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier	ISSN: 2045-1253
ispartof	Therapeutic advances in psychopharmacology, 2017-11, Vol.7 (11), p.237-239
issn	2045-1253 2045-1261
language	eng
recordid	cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5638160
source	Sage Journals GOLD Open Access 2024
subjects	Antipsychotics Schizophrenia
title	The prospects of cariprazine in the treatment of schizophrenia
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T08%3A50%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_AFRWT&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20prospects%20of%20cariprazine%20in%20the%20treatment%20of%20schizophrenia&rft.jtitle=Therapeutic%20advances%20in%20psychopharmacology&rft.au=Scarff,%20Jonathan%20R.&rft.date=2017-11-01&rft.volume=7&rft.issue=11&rft.spage=237&rft.epage=239&rft.pages=237-239&rft.issn=2045-1253&rft.eissn=2045-1261&rft_id=info:doi/10.1177/2045125317727260&rft_dat=%3Cproquest_AFRWT%3E1958544394%3C/proquest_AFRWT%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2424661704&rft_id=info:pmid/29090086&rft_sage_id=10.1177_2045125317727260&rfr_iscdi=true